7 results
Recurrent / Breakthrough DVT During Anticoagulation

Subtherapeutic Anticoagulation
Hypercoagulable State 
 - Antithrombin deficiency 
 - Hypercoagulability ot
Subtherapeutic Anticoagulation ... Recurrent #DVT #VTE ... #anticoagulation ... #hematology #differential ... #algorithm
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... body mass index; VTE ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
for VTE in Malignancy ... thrombosis in cancer ... risk of recurrent VTE ... #Cancer #Algorithm ... #Anticoagulation
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management Algorithm ... #Anticoagulation ... Breakthrough #Thrombosis #Algorithm ... #Extension #VTE ... Management #Diagnosis #Differential
Endocarditis Summary

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV substance use
• IV catheter
• Recent
Endocarditis Summary ... Marantic (NTBE) Differential ... cultures • 2D Echo TTE ... • TTE nondiagnostic ... cause + Systemic anticoagulation
Endocarditis - Overview and Differential Diagnosis Framework

Who?
Infectious:
• Pre-existing valvular disease
• Prosthetic valve
• Congenital heart disease
• IV
Endocarditis - Overview ... and Differential ... ○ TTE nondiagnostic ... cause + Systemic anticoagulation ... #Differential #
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment Algorithm ... at 3 Months • Cancer ... therapy - Second VTE ... Thromboembolism #Treatment #Algorithm ... management #hematology #anticoagulation